Marker Exchange Mutagenesis of mxaF,Encoding the Large Subunit of the Mxa Methanol Dehydrogenase,in Methylosinus trichosporium OB3b

Methanotrophs have remarkable redundancy in multiple steps of the central pathway of methane oxidation to carbon dioxide. For example, it has been known for over 30 years that two forms of methane monooxygenase, responsible for oxidizing methane to methanol, exist in methanotrophs, i.e., soluble methane monooxygenase (sMMO) and particulate methane monooxygenase (pMMO), and that expression of these two forms is controlled by the availability of copper. Specifically, sMMO expression occurs in the absence of copper, while pMMO expression increases with increasing copper concentrations. More recently, it was discovered that multiple forms of methanol dehydrogenase (MeDH), Mxa MeDH and Xox MeDH, also exist in methanotrophs and that the expression of these alternative forms is regulated by the availability of cerium. That is, expression of Xox MeDH increases in the presence of cerium, while Mxa MeDH expression decreases in the presence of cerium. As it had been earlier concluded that pMMO and Mxa MeDH form a supercomplex in which electrons from Mxa MeDH are back donated to pMMO to drive the initial oxidation of methane, we speculated that Mxa MeDH could be rendered inactive through marker-exchange mutagenesis but growth on methane could still be possible if cerium was added to increase the expression of Xox MeDH under sMMO-expressing conditions. Here we report that mxaF, encoding the large subunit of Mxa MeDH, could indeed be knocked out in Methylosinus trichosporium OB3b, yet growth on methane was still possible, so long as cerium was added. Interestingly, growth of this mutant occurred in both the presence and the absence of copper, suggesting that Xox MeDH can replace Mxa MeDH regardless of the form of MMO expressed.     

池养鲤和草鱼血液学指标的研究

1.鲤鱼和草鱼的血液细胞包含红血球、淋巴球、单核球、嗜中性球、嗜酸性球及纺锤细胞。没有见到嗜碱性球。2.鲤鱼及草鱼的红血球数及血红蛋白量,在正常条件下,与水中溶氧量及成熟系数成十分显著的负相关。成熟雌鲤的红血球数(y)与溶氧量(x1)及成熟系数(x2)的迥归公式为:y=122+2.9x1-1.2x2。3.性腺发育程度及生殖活动强烈地影响鱼类血液有形成分。在生殖季节雄鱼的红血球数及血红蛋白量比雌鱼高,红血球沉降率则相反。白血球则在生殖季节及性腺退化吸收时比较活跃,而在非生殖季节两性之间无明显差异。4.发育成熟的雌鲤,经注射垂体后,无论产卵与不产卵其红血球数及血红蛋白量都下降,自然产卵的雌鲤亦然。5.雌鲤的红血球沉降率在临近产卵时急剧增加,而且比雄鲤明显地高。至于饥饿则对红血球沉降率无明显影响。6.在池养条件下鲤鱼的红血球数、血红蛋白量以及血式的个体差异较小,可望成为这类鱼的有应用价值的正常生理指标。       

利用CRISPR/Cas9n double nick系统构建人DNAH2基因敲除的U2OS细胞株

基于CRISPR/Cas9n double nick技术构建人DNAH2(Homo sapiens dynein,axonemal,heavy chain 2)基因敲除的U2OS稳定细胞株,旨在研究DNAH2基因的生物学功能。首先设计并合成A、B两个sg RNA(Single guide RNA)以及各自的互补链,退火连接形成DNAH2 sg RNA-A、B双链,再分别与带有BbsⅠ粘性末端的p X462线性载体相连,形成p X462-DNAH2-A、p X462-DNAH2-B重组真核表达质粒。质粒共转染至U2OS细胞后,加入嘌呤霉素,以有限稀释法获得阳性单克隆细胞株,再以蛋白印迹实验检测DNAH2蛋白的表达,最后通过PCR-基因测序技术分析突变特点。结果显示A、B sg RNA双链成功插入p X462载体,U2OS-DNAH2-KO单克隆细胞株中DNAH2蛋白不表达,DNAH2基因发生移码突变,从而证实利用CRISPR/Cas9n double nick系统成功构建人DNAH2基因敲除的U2OS稳定细胞株,为研究DNAH2基因提供有利工具。     

Catesbeianin-1, a novel antimicrobial peptide isolated from the skin of <Emphasis Type="Italic">Lithobates catesbeianus</Emphasis> (American bullfrog)

Objectives

To identify and characterize a novel antimicrobial peptide, catesbeianin-1.

Results

Catesbeianin-1 is 25 amino acids long and is α-helical, cationic and amphipathic. It had antimicrobial activity against Gram-positive and Gram-negative bacteria. It was resistant against trypsin and pepsin. Catesbeianin-1 exhibited moderate hemolytic activity (approx 8%) at 100 μg/ml, and its HC₅₀ (50% hemolytic concentration) was 300 μg/ml. Its cytotoxicity was approx 10–20% at 100 μg/ml, and its CC₅₀ (50% cytotoxic concentration) was >100 μg/ml. The LD₅₀ of catesbeianin-1 in mice was 80 mg/kg. At 3.1 µg/ml, catesbeianin-1 significantly inhibited the growth of methicillin-resistant Staphylococcus aureus.

Conclusions

A new antimicrobial peptide from the skin of Lithobates catesbeianus (American bullfrog) may represent a template for the development of novel antimicrobial agents.

     

Review: Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

Background

In addition to nonmodifiable genetic risk factors, potentially modifiable factors such as hypertension, hyperlipidemia and environmental exposures have been identified as risk factors for Alzheimer disease. In this article, we provide physicians with practical guidance on risk assessment and primary prevention of Alzheimer disease based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, held in March 2006.

Methods

We developed evidence-based guidelines using systematic literature searches, with specific criteria for study selection and quality assessment, and a clear and transparent decision-making process. We selected studies published from January 1996 to December 2005 that met the following criteria: dementia (all-cause, Alzheimer disease or vascular dementia) as the outcome; longitudinal cohort study; study population broadly reflective of Canadian demographics; and genetic risk factors and general risk factors (e.g., hypertension, education, occupation and chemical exposure) identified. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care.

Results

Of 3424 articles on potentially modifiable risk factors for dementia, 1719 met our inclusion criteria; 60 were deemed to be of good or fair quality. Of 1721 articles on genetic risk factors, 62 that met our inclusion criteria were deemed to be of good or fair quality. On the basis of evidence from these articles, we made recommendations for the risk assessment and primary prevention of Alzheimer disease. For the primary prevention of Alzheimer''s disease, there is good evidence for controlling vascular risk factors, especially hypertension (grade A), and weak or insufficient evidence for manipulation of lifestyle factors and prescribing of medications (grade C). There is good evidence to avoid estrogens and high-dose (> 400 IU/d) of vitamin E for this purpose (grade E). Genetic counselling and testing may be offered to at-risk individuals with an apparent autosomal dominant inheritance (grade B). Screening for the apolipoprotein E genotype in asymptomatic individuals in the general population is not recommended (grade E).

Interpretation

Despite the personal and societal burden of dementia, our understanding of genetic predisposition to dementias and the contribution of other risk factors remains limited. More importantly, there are few data to explain the overall risks and benefits of prevention strategies or their impact of risk modification.

Articles to date in this series

• Chertkow H. Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. CMAJ 2008;178:316-21.